Effect of curcumin treatment on protein phosphorylation in K562 cells

Annals of the New York Academy of Sciences

Volumn 1095, Issue , 2007, Pages 377-387

  Blasius, Romain ^a   Dicato, Mario ^a   Diederich, Marc ^a  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

Author keywords

Curcumin; K562; Leukemia; Phosphoproteins

Indexed keywords

ADDUCIN; ALPHA ADDUCIN; CURCUMIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLIN DEPENDENT KINASE 1; GAMMA ADDUCIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE R; PROTEIN TYROSINE KINASE; RAF PROTEIN; RETINOBLASTOMA PROTEIN; S6 KINASE; SMAD1 PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; PHOSPHOPROTEIN;

CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROTEIN PHOSPHORYLATION; ARTICLE; CELL STRAIN K 562; ERYTHROLEUKEMIA; METABOLISM; PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS; CURCUMIN; HUMANS; K562 CELLS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; PHOSPHOPROTEINS; PHOSPHORYLATION;

EID: 34247874525     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1397.041     Document Type: Conference Paper

References (38)

1. BALUNAS, M.J. & A.D. KINGHORN. 2005. Drug discovery from medicinal plants. Life Sci. 78: 431-441.
2. TREASURE, J. 2005. Herbal medicine and cancer: an introductory overview. Semin. Oncol. Nurs. 21: 177-183.
3. FOLMER, F., R. BLASIUS, F. MORCEAU, et al. 2006. Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives. Biochem. Pharmacol. 71: 1206-1218.
4. DUVOIX, A., R. BLASIUS, S. DELHALLE, et al. 2005. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 223: 181-190.
5. MAHESHWARI, R.K., A.K. SINGH, J. GADDIPATI, et al. 2006. Multiple biological activities of curcumin: a short review. Life Sci. 78: 2081-2087.
6. SHISHODIA, S., G. SETHI & B.B. AGGARWAL. 2005. Curcumin: getting back to the roots. Ann. N. Y. Acad. Sci. 1056: 206-217.
7. MULLER, M.M., E. SCHREIBER, W. SCHAFFNER, et al. 1989. Rapid test for in vivo stability and DNA binding of mutated octamer binding proteins with 'mini-extracts' prepared from transfected cells. Nucleic Acids Res. 17: 6420.
8. BIANCHI, G., P. FERRARI & J.A. STAESSEN. 2005. Adducin polymorphism: detection and impact on hypertension and related disorders. Hypertension 45: 331-340.
9. MATSUOKA, Y., X. LI & V. BENNETT. 2000. Adducin: structure, function and regulation. Cell Mol. Life Sci. 57: 884-895.
10. FOWLER, L., J. EVERITT, J.L. STEVENS, et al. 1998. Redistribution and enhanced protein kinase C-mediated phosphorylation of alpha- and gamma-adducin during renal tumor progression. Cell Growth Differ. 9: 405-413.
11. CASTEDO, M., J.L. PERFETTINI, T. ROUMIER, et al. 2002. Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ. 9: 1287-1293.
12. MAYYA, V., K. REZAUL, L. WU, et al. 2006. Absolute quantification of multi-site phosphorylation by selective reaction monitoring mass spectrometry: determination of inhibitory phosphorylation status of cyclin dependent kinases. Mol. Cell. Proteomics
13. HOEFLICH, K.P., J. LUO, E.A. RUBIE, et al. 2000. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406: 86-90.
14. ALI, A., K.P. HOEFLICH & J.R. WOODGETT. 2001. Glycogen synthase kinase-3: properties, functions, and regulation. Chem. Rev. 101: 2527-2540.
15. RUSSELLO, S.V. & S.K. SHORE. 2004. SRC in human carcinogenesis. Front Biosci. 9: 139-144.
16. MICHIE, A.M. & R. NAKAGAWA. 2005. The link between PKC alpha regulation and cellular transformation. Immunol. Lett. 96: 155-162.
17. OLIVEIRA, A.M., J.S. ROSS & J.A. FLETCHER. 2005. Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers. Am. J. Clin. Pathol. 124(Suppl): S16-S28.
18. SAUERBREY, A., G. STAMMLER, F. ZINTL, et al. 1998. Expression of the retinoblastoma tumor suppressor gene (RB-1) in acute leukemia. Leuk. Lymphoma 28: 275-283.
19. CHOUDHURI, T., S. PAL, T. DAS, et al. 2005. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J. Biol. Chem. 280: 20059-20068.
20. CONKRIGHT, M.D. & M. MONTMINY. 2005. CREB: the unindicted cancer co-conspirator. Trends Cell. Biol. 15: 457-459.
21. JOHANNESSEN, M., M.P. DELGHANDI & U. MOENS. 2004. What turns CREB on? Cell. Signal. 16: 1211-1227.
22. BALASUBRAMANYAM, K., R.A. VARIER, M. ALTAF, et al. 2004. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J. Biol. Chem. 279: 51163-51171.
23. LEE, J.T., JR. & J.A. MCCUBREY. 2002. The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia 16: 486-507.
24. MASAMUNE, A., N. SUZUKI, K. KIKUTA, et al. 2006. Curcumin blocks activation of pancreatic stellate cells. J. Cell. Biochem. 97: 1080-1093.
25. SIWAK, D.R., S. SHISHODIA, B.B. AGGARWAL, et al. 2005. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/ extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer 104: 879-890.
26. COLLETT, G.P. & F.C. CAMPBELL. 2004. Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis 25: 2183-2189.
27. KAKAR, S.S. & D. ROY. 1994. Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. Cancer Lett. 87: 85-89.
28. WITTIG, I. & B. GRONER. 2005. Signal transducer and activator of transcription 5 (STAT5), a crucial regulator of immune and cancer cells. Curr. Drug Targets Immune. Endocr. Metabol. Disord. 5: 449-463.
29. RAJASINGH, J., H.P. RAIKWAR, G. MUTHIAN, et al. 2006. Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia. Biochem. Biophys. Res. Commun. 340: 359-368.
30. BHARTI, A.C., N. DONATO & B.B. AGGARWAL. 2003. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J. Immunol. 171: 3863-3871.
31. ECKERT, R.L., J.F. CRISH, T. EFIMOVA, et al. 2006. Opposing action of curcumin and green tea polyphenol in human keratinocytes. Mol. Nutr. Food Res. 50: 123-129.
32. DUNN, K.L., P.S. ESPINO, B. DROBIC, et al. 2005. The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem. Cell. Biol. 83: 1-14.
33. DUMAZ, N. & R. MARAIS. 2003. Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras. J. Biol. Chem. 278: 29819-29823.
34. LEE, M.R. & C. DOMINGUEZ. 2005. MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alpha protein. Curr. Med. Chem. 12: 2979-2994.
35. WYSZOMIERSKI, S.L. & D. YU. 2005. A knotty turnabout? Akt1 as a metastasis suppressor. Cancer Cell 8: 437-439.
36. KIM, J.H., C. XU, Y.S. KEUM, et al. 2006. Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin. Carcinogenesis 27: 475-482.
37. LIN, J.K. 2004. Suppression of protein kinase C and nuclear oncogene expression as possible action mechanisms of cancer chemoprevention by Curcumin. Arch. Pharm. Res. 27: 683-692.
38. BEEVERS, C.S., F. LI, L. LIU, et al. 2006. Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells. Int. J. Cancer 119(4): 757-764.